Erlangen, Germany

Ersan Özmen

This inventor holds 1 USPTO granted patent. Top assignee: Humanoptics Ag. Active years: 2007.


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2007

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ersan Özmen: Innovator in Intraocular Lens Technology

Introduction

Ersan Özmen is a notable inventor based in Erlangen, Germany. He has made significant contributions to the field of ophthalmology, particularly in the development of intraocular lenses. His innovative designs aim to improve the quality of life for individuals undergoing cataract surgery.

Latest Patents

Ersan Özmen holds a patent for an intraocular lens designed for implantation in the capsule of the eye. This lens features an optic with a substantially circular rim, an optical axis, and a lens plane that extends vertically of the optical axis. The design includes at least two haptics that support the optic on the capsule. These haptics are fixed to the optic and are made from reversibly deformable material. Each haptic consists of a first Z-shaped haptic clamp and a second Z-shaped haptic clamp, both articulated to the rim, along with a connecting clamp that is concave in relation to the optical axis, uniting the two haptic clamps.

Career Highlights

Ersan Özmen is associated with Humanoptics AG, a company that specializes in innovative solutions for ophthalmic surgery. His work has contributed to advancements in intraocular lens technology, enhancing surgical outcomes for patients.

Collaborations

Ersan has collaborated with notable colleagues, including Arthur Meβner and Tim Use. Their combined expertise has fostered innovation in the field of ophthalmology.

Conclusion

Ersan Özmen's contributions to intraocular lens technology exemplify his commitment to improving patient care in ophthalmology. His innovative designs and collaborations continue to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…